Lexeo Therapeutics, Inc. LXEO
NASDAQ · United States · Health Technology
$3.53-0.09 (-2.49%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.30 | -0.29 | -5.2% | $0 | — | +3.8%$4.78→$4.96 |
| Q1 2026 | 2026-05-11 | -0.25 | -0.30 | +16.7% | — | — | -2.2%$5.83→$5.70 |
| Q4 2025 | 2026-03-30 | -0.27 | -0.30 | +10.0% | — | — | +5.1%$5.46→$5.74 |
| Q3 2025 | 2025-11-05 | -0.33 | -0.48 | +31.2% | — | — | +0.8%$8.35→$8.42 |
| Q2 2025 | 2025-08-14 | -0.68 | -0.66 | -3.0% | — | — | — |
| Q1 2025 | 2025-05-12 | -0.99 | -0.77 | -28.6% | — | — | — |
| Q4 2024 | 2025-03-24 | -0.78 | -0.78 | 0.0% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.89 | -0.67 | -32.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.